Altimmune, Inc.
ALT
$7.03
$0.253.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.24M | -95.06M | -103.52M | -101.35M | -92.77M |
| Total Depreciation and Amortization | 160.00K | 238.00K | 319.00K | -270.00K | -836.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.13M | 10.50M | 22.25M | 22.87M | 22.23M |
| Change in Net Operating Assets | -1.39M | 4.48M | 2.84M | 7.26M | -1.39M |
| Cash from Operations | -80.33M | -79.85M | -78.12M | -71.49M | -72.76M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.03M | -28.39M | -49.98M | -46.77M | -39.10M |
| Cash from Investing | 6.03M | -28.39M | -49.98M | -46.77M | -39.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 45.48M | 10.89M | 73.60M | 73.92M | 87.13M |
| Repurchase of Common Stock | -928.00K | -850.00K | -885.00K | -883.00K | -1.14M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.00K | -- | 0.00 | 0.00 | 152.00K |
| Cash from Financing | 44.42M | 10.04M | 72.71M | 73.04M | 86.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.87M | -98.19M | -55.38M | -45.22M | -25.71M |